There are errors in [Table 1](#pone-0106358-t001){ref-type="table"}. The corrected table is shown below.

###### Studies that assessed preeclampsia screening using metabolomics techniques. PE: preeclampsia; DR: detection rate; FPR: false positive rate; MC: maternal characteristics; UtA: Uterine artery Doppler measurement; CRL: crown- rump-length.
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  Study                                   Sample taken (weeks)   Body fluid   Numbers   Gestational age at delivery   Number of metabolites   DR (at FPR)                       
  -------------------------------------- ---------------------- ------------ --------- ----------------------------- ----------------------- ------------- -------------------- --------------
  Kenny et al \[13\] *Discovery study*           15 ± 1            plasma       60                  60                     40.1 (1.1)         37.5 (2.8)            14            77% (10%)
  *Validation study*                             15 ± 1            plasma       40                  39                     38.1 (2.3)         40.0 (1.3)            14            73% (10%)
  Odibo et al \[14\]                           12.1 (0.6)          serum        41                  41                     39.0 (2.8)         35.3 (4.1)            4             50% (10%)
  Bahado-Singh et al \[15\]                   11+0 -- 13+6         plasma       60                  30                    "unaffected"        \< 34 weeks         4 + MC         75.9% (4.9%)
                                                                                                                                                            3 + MC + UtA + CRL   82.6% (1.6%)
  Bahado-Singh et al \[16\]                   11+0 -- 13+6         serum        119                 30                    "unaffected"        ≥ 37 weeks            2             56.7% (5%)
